Geneos Wealth Management Inc. Clovis Oncology, Inc. Transaction History

Geneos Wealth Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 Sep 07, 2021	SELL	$50.12 - $67.72 $1,202 - $1,625	-24 Closed	0 $0
Q3 2017 Sep 07, 2021	SELL	$67.17 - $84.81 $44,265 - $55,889	-659 Reduced 96.49%	24 $1,000
Q2 2017 Sep 07, 2021	SELL	N/A	-48 Reduced 6.57%	683 $63,000
Q1 2017 Sep 07, 2021	BUY	N/A	367 Added 100.82%	731 $46,000
Q4 2016 Sep 07, 2021	BUY	N/A	364	364 $16,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

Stay updated on Geneos Wealth Management Inc. with notifications on news.